BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development

  April 21, 2025

   · 

  7 min read
• Press Releases

  4M Therapeutics to Present at the Upcoming American Psychological Association and American Society of Clinical Psychopharmacology Annual Meetings

  April 21, 2025

   · 

  1 min read
• Press Releases

  Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors

  April 21, 2025

   · 

  5 min read
• Press Releases

  Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences

  April 21, 2025

   · 

  3 min read
• Press Releases

  Diabetes Care Publishes Results From Prevalence Phase Of Corcept’s CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes

  April 21, 2025

   · 

  4 min read
• Press Releases

  BostonGene Announces Participation at the American Association for Cancer Research Annual Meeting 2025

  April 21, 2025

   · 

  4 min read
• Press Releases

  Enlivex Announces Completion of Enrollment In The Phase II stage Of Its Phase I/II Trial Evaluating Allocetra In Patients With Moderate To Severe Knee Osteoarthritis

  April 21, 2025

   · 

  5 min read
• Press Releases

  Integrated DNA Technologies Introduces Transformative Hybridization Capture Solution to Accelerate Cancer Research

  April 21, 2025

   · 

  3 min read
• Press Releases

  United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference

  April 21, 2025

   · 

  5 min read
• Press Releases

  Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP

  April 21, 2025

   · 

  5 min read